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Abstract

IDENTIFICATION OF APOPTOSIS PATHWAY IN TREACHER COLLINS
SYNDROME
By Khaled Alsayegh, B.S
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director: Rita Shiang
Associate Professor, Department of Human & Molecular Genetics

Treacher Collins Syndrome (TCS) is a rare autosomal dominant disorder
characterized by severe craniofacial defects. The syndrome is associated with mutations in
the TCOF1 gene, which encodes a nucleolar phosphoprotein called treacle. Model
organisms have been generated to model the disease and have revealed knowledge about
the etiology and pathogenesis of the disorder. The craniofacial abnormality observed in
TCS patients is found to be caused by an increased level of apoptosis in the
neuroepithelium and from this it has been suggested that treacle is important for proper
formation and proliferation of neural crest cells that will ultimately contribute to the face.
The best attempt to rescue the phenotype of TCS was made by inhibiting the expression of
p53 in both zebrafish and mouse models. Although both rescues were successful, it resulted
in tumor formation in mice which limits the potential of using this type of rescue in
humans. Therefore, it is very important to identify p53-downstream genes that were not
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related to cancer and use them to interrupt the apoptosis pathway and hence rescuing the
phenotype.
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CHAPTER 1: Neural Crest Cells and Craniofacial Development
History of Neural Crest Cells

“What role these cells play in the formation of later tissues I do not know, nor do I know
what becomes of the “lost” portions of the neural crest which lie between the spinal
ganglia, but it has become evident that the whole question of the nature of “mesoderm” in
Vertebrates needs revision founded on fact rather than theory.”
—J. B. Platt, 1893
Neural crest cells were first called Zwischenstrang, which meant the intermediate
cord, when the Swiss embryologist, Wilhelm His, identified these cells sandwiched
between the epidermal ectoderm and the neural tube in the neurula stage chick embryos.
The neural crest was first named by Arthur Milnes Marshall. (Hall, 1999).
In the early 1890’s, neural crest cells were still thought to have only been the source
of neurons and ganglia. But in 1897, Julia Platt showed that the cartilages of the head and
face and the cells that formed the teeth, originate from neural crest cells (Platt et al., 1897).
This was shown in the mud puppy, Necturus.
The number of tissues that the neural crest cells contribute to is very large (Figure
1). In addition to being the precursor of melanocytes, neurons and glia of the peripheral
nervous system, cranial neural crest cells contribute to most of the cartilage, bone and
connective tissue of the face. Because these multipotent cells have self renewal properties,
they were considered to be stem cells or stem cell like cells (Labonne et al., 1998).

Figure 1: Shows the different cell types and tissues or organs derived from neural crest
cells.
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Trainor et al., 2003.

Neural crest cells are induced at the border between the neural plate and the nonneural ectoderm. They undergo epithelial to mesenchymal transition. They delaminate and
migrate to ventral regions and ultimately differentiate into a variety of tissues.
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Induction of Neural Crest Cells
Neural crest cells arise at the dorso-lateral edge of the closing neural fold along the
entire length of the vertebrate embryo neuraxis (Reviewed in Trainor, 2003). This occurs
specifically at the neural plate border, between the dorsal region of neural plate and the
non-neural ectoderm (surface ectoderm).
It has been shown that, cells in the dorsal region of the neural tube can give rise to
both, neural tube and neural crest derivatives. Since proteins such as, bone morphogenetic
proteins (BMPs) which is a member of the growth factor beta family (Liem et al., 1995),
fibroblast growth factors (FGFs) (Monosoro et al., 2003) and the Wnt signal family are
critical in determining the fate of neural plate cells (neural or epidermal), it is expected that
these proteins also play a role in the induction and the specification and the differentiation
of neural crest cells.
In the stage of open neural plate, BMP proteins are highly expressed in the nonneural ectoderm. But while the neural tube is closing, levels of expression of BMP goes
down in the non-neural ectoderm, but continues to be expressed in the dorsal neural tube.
These findings, led to the hypothesis that BMP secreted by the non-neural ectoderm induce
the neural plate to induce the formation and migration of neural crest cells. A study was
performed by Liem et al, (1995), where the group investigated what factors control the
dorsalization the neural plate. The group examined the hypothesis that, adjacent tissues
may be inducing the differentiation. They examined the effect of both the epidermal
ectoderm and the paraxial mesoderm, since these tissues have been implicated in the
differentiation of neural crest cells. Ventral neural plate explants were grown in contact
with surface ectoderm or paraxial mesoderm derived from stage 10 quail or chick embryo.
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By 40 hours, ventral and intermediate explants grown in contact with the epidermal
ectoderm, started producing neural crest cells. In the same study, the pattern of expression
of BMP proteins, especially BMP4 and 7, in the neural tube, indicated its potential of
driving the differentiation. This was also supported by the induction of slug, which is a
marker of neural crest cells, by BMP4.
The restriction of neural cells generation to the neural and epidermal ectoderm
boundary is controlled by factors that are upstream of BMP4. In the epidermal ectoderm
Delta1, which is a gene that encodes a ligand that specifically binds to Notch, regulates
slug expression through the BMP4 signaling pathway (Figure 2) (Endo et al., 2002).
Therefore, the inhibition of Delta in the non-neural ectoderm will repress the formation of
Slug. Which can then be rescued by BMP4 expression. The pathway starts by the
expression of Delta1 from the non-neural ectoderm, which activates notch, that ultimately
promote expression of BMP4 in the non-neural ectoderm. It was also shown that that
overexpression of Notch will lead to down regulation of both Slug and BMP4 (Reviewed in
Trainor et al., 2003). This implies that Notch is needed in modest levels in order to promote
activation of BMP4 and Slug. Interestingly, although Notch will promote the expression of
BMP4 in the epidermal ectoderm, it inhibits Slug’s expression in this region. In this way,
Notch defines the signals for neural crest specification only in the neural folds. With this
system, Notch can be thought to tightly regulate the region for the induction of neural crest,
by restricting induction by BMP4 to the neural plate border (Endo et al., 2002).
A study done by Garcia-Castro et al., (2002) showed that BMP4 expression alone is
not enough to induce neural crest cells formation. In chemically defined DMEM without
supplementation, BMP signaling alone was not able to induce the formation of neural crest
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cells in avian neuroepithelial explants. Also in this study, the group showed that Wnt
signaling, which is a group of proteins that participate in pathways important in
development, was able to induce the formation of neural crest cells. This was indicated by
the increased expression of slug. In addition when the expression of Wnt was inhibited,
slug expression decreased and the formation of neural crest cells was abrogated.
In another study that also showed the importance of Wnt in neural crest cells
induction, by Saint-Jeannet et al., (1997). In this study Wnt was overexpressed in xenopus
embryo. This resulted in an increase in several neural crest markers. This is also supported
by the observation that Wnt1/Wnt3a double mutant mice exhibit skeletal abnormalities, and
extreme reduction in cranial and spinal sensory neurons, all of which are derived from
neural crest cells (Ikeya et al., 1997). A very recent study by Patthey et al., (2009), showed
that, it’s the interaction of both BMP4 and Wnt that is important in determining the fate in
either being in the neural-epidermal border or in the epidermal region.
In 2003, Monsoro-Burq et al, showed that FGF signaling from the mesoderm is also
an important player in neural crest induction. From all of these experiments, we can
conclude that BMP, Wnt and FGF signaling pathways, are important and play a critical role
in the neural crest cells formation.
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Figure 2: The hypothesized model for the regulation of BMP signaling, Notch signaling
and Slug expression.
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Endo et al, 2002.

Delamination of Neural Crest Cells
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The migration of the neural crest cells occur almost at the same time of their
induction along the dorso-lateral edge of the neural plate. This begins with their transition
to the mesenchymal type before they can migrate.
The transition of neural crest cells from epithelial cells to mesenchymal cells, is
marked with the change of expression of the cell adhesion proteins. Most important, are the
cadherin proteins. Cadherins get their name from their dependence on calcium for their
function, they were first called, calcium dependant adhesion molecules. These protein are
transmembrane proteins that play an important role in cell adhesion, ensuring cells within
tissues are bound together. It was found that during delamination, neural crest cells
downregulate multiple adhesion molecules such as N-Cadherin and Cadherin6B and it
upregulates Cadherin7 and Cadherin11 (Kimura et al., 1995; Nakagawa et al., 1998). In
one study, the group overexpressed flag-tagged N-Cadherin and Beta-Galactosidase
(control) by injecting adenovirus shuttle vector with the coding sequences into the lumen of
the neural tube in chick embryos (Nakagawa et al., 1998). After detecting the ectopic
expression of N-Cadherin, the effect that this expression had on the delamination or the
migration of the neural crest cells was observed. The cells that were positive for Betagalactosidase, had normal delamination and migration (detected by whole mount staining).
However, in embryos expressing ectopic N-Cadherin, no infected cells were found
migrating along the dorso-lateral region (detected using an anti-FLAG antibody). Cells
accumulated in the mid-line of the neural tube, some of which had invaded the lumen of
the neural tube. These results supported the idea that the control of cadherin activity or
expression is essential for neural crest emigration.
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One of the most important hallmarks of neural crest cells formation in addition to
Slug, is a transcription factor called Snail. When Snail was overexpressed in epithelial
cells, the cells adopted a fibroblastoid phenotype and acquired tumorigenic and invasive
properties (Cano et al., 2000). Thus, snail acted as a transcriptional repressor of ECadherin. This inhibition is expected to prevent the epithelial-mesenchymal transition and
subsequently inhibit neural crest cells migration. So there is a cadherin switch that needs to
be balanced for the neural crest cell to migrate. It was also shown that when Slug antisense
mRNA oligonucleotide was used in avian embryos, it resulted in the inhibition of cranial
neural crest migration.
BMP expression as was mentioned above is important for neural crest cell
induction. It was found that BMPs also play a role in delamination. Upstream, is the DeltaNotch signaling pathway, that promotes BMP4 and at the same time, it inhibits Slug
expression. This suggest a mechanism through which these players tightly control the
formation and delamination of neural crest cells at the neural-epidermal junction .
Another factor that is thought to be important in the delamination of neural crest
cells, is the GTP-binding protein RhoB. The importance of this protein was first suggested,
because of its selective expression in the dorsal neural tube and its transient expression in
the neural crest. RhoB is also induced by BMPs, and the inhibition of RhoB results in the
prevention of the delamination of neural crest from the dorsal epithelium (Liu and Jessell,
1998).
In an attempt to identify the mechanism by which a subset of dorsal neural tube
cells ultimately give rise to neural crest, Barembaum et al., (2000), screened for molecules
expressed in the early developing nervous system. One of these molecules was Noelin-1.
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The delamination and migration of neural crest cells from the neural tube after the
conversion of the neuroepithelial precursors from epithelial to mesenchymal, is a transient
event. The maintenance of neuroepithelial precursors to keep producing neural crest cells is
what is most important. This appears to be regulated by the glycoprotein, Noelin-1.
Noelin-1 is initially expressed along the edges lateral edges of the neural plate but is also
expressed later in migrating neural crest cells. Overexpression of Noelin-1 in the neural
tube using retroviral infection resulted in increased numbers of neural crest cells over the
dorsal neural tube in the Noelin-1 injected embryos (detected by staining for the neural
crest marker HNK-1). This suggested an over production of cranial neural crest cells. From
these results, Noelin-1 may be maintaining the period during which the neural epithelium is
competent to generate neural crest cells.
Migration of Neural Crest Cells
Migrating cranial neural crest cells can be divided into forebrain, midbrain and hindbrain.
These cells move along precise, species specific and region specific pathways between the
cranial ectoderm and mesoderm (Reviewed in Walker et al., 2006). The most profound
aspect in the migration and patterning of the cephalic neural crest cells migration is the
apparent segregation of the frontnasal, first pharyngeal arch, second arch, and third arch
population from one another, the patterns of which are highly conserved in all vertebrate
species as disparate as amphibians, teleosts, avians, marsupials and mammals (Figure 3).
Forebrain and rostral midbrain neural crest cells colonize the frontonasal and periocular
regions. Caudal midbrain derived neural crest cells populate the maxillary component of
the first pharyngeal arch (Reviewed in Walker et al., 2006). The hindbrain is transiently
partitioned into seven segments called rhombomeres (Vaage et al., 1969) and neural crest
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cells emigrate form each of the rhombomeres forming discrete segregated streams that
populate the first, second, third and fourth pharyngeal arches. The segregation of distinct
cranial neural crest cells populations is critical to prevent fusions of the cranial ganglia and
skeletal elements and also to prevent mixing of neural crest cells with different genetic
constitutions (Golding J et al., 2000) and this is controlled by the ectoderm, mesoderm and
endoderm tissues with which the neural crest cells interact.
Movement of the neural crest cells, mesodermal muscle precursors and ectoderm
into the pharyngeal arches is dependent on one another. The neural crest cells that arise
from the caudal midbrain and anterior hindbrain are always associated with muscle
precursors and ectoderm cells that arise from the same axial level. All of them occupy the
first pharyngeal arch with the mesoderm forming the central core or the muscle plates.
These muscle plates are surrounded by neural crest cells which are surrounded by the
ectoderm. This arrangement creates boundaries which will be conserved through later
stages of development when the muscles and their connective tissues move to other parts of
the head. This orchestration is also seen in the cranial motor nerves and precursors of
epipharyngeal placode.
All these data suggest that early registration between the different tissues in the
head during early embryogenesis is critical for the establishment of the foundations of the
vertebrate craniofacial development.

Figure 3: Shows the migration of neural crest cells in rat embryo from the neural tube in
segregated distinct streams into the branchial arches. Neural crest derivatives are distinct
for erach branchial arch.
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From Gilbert., 1994. page: 294.

Pathways Specifications of Neural Crest Migration
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Cranial neural crest cells derived from the hindbrain migrate ventro-laterally from
the neural tube in three distinct distinct subectodermal streams adjacent to the even
numbered rhombomeres, rhombomeres 2, 4 and 6. These three travelling streams of neural
crest cells accumulate or populate the first, second and third branchial arches and
ultimately give rise to a wide variety of cell lineages which are specific for each branchial
arch.
The underlying cause for the neural crest exclusion zones adjacent to the odd
numbered rhombomeres, rhombomeres 3 and 5, remained puzzling for a long time. In a
study done by Graham et al 1993, the group found an increased level of apoptosis near the
rhombomeres 3 and 5 when they stained with acridine orange (in avian embryo). These
results were further confirmed with electron microscopy.
In an attempt to rescue r3 and r5 crest from cell death, the group used tissue culture.
Individual stage 10 rhombomeres, completely purified from contaminating mesenchyme,
were prepared and were plated onto fibronectin/poly-L-lysine substrata to allow neural
crest cells to crawl out. Surprisingly, both even and odd-numbered rhombomeres produced
cells that migrated away from the neural tube and that these cells had a typical neural crest
cell morphology. The group then stained the explants for HNK-1 which is the marker of
neural crest cells to detect if there were any differences between the odd and the even. So
when single rhombomere was dissected from the animal and grown in vitro, they produced
healthy neural crest cells.
It seems that signals from the even numbered rhombomeres which are mediated by
BMP4 induced Msx2 expression in rhombomeres 3 and 5, causes the apoptotic elimination
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of premigratory neural crest cells in rhombomeres 3 and 5. As a result neural crest cells
segregate into discrete streams.
Another study done by Ellies et al, (2002), added another player to the game. In this
study the group was able to inhibit apoptosis. This was done by the over-expression of Wnt
antagonist, sFRP2, which inhibited BMP signaling pathway. These data suggest that, the
apoptotic elimination of neural crest cells precursors is modulated by a Wnt – BMP
signaling pathway. Furthermore, that this machinery is important in the evolutionary
elimination of unnecessary muscle attachment sites (Ellies et al., 2002; Reviewed in
Trainor, 2003).
Because early examinations of neural crest cell death were performed in serum rich
media, the hypothesis that proposes BMP4-Msx2 mediated cell death in odd rhombomeres
remained controversial. When studies have been performed to repeat the findings of BMP4
dependence in chemically defined media instead of the serum, the results were not
replicated. The studies failed to demonstrate any significant link between BMP signaling
pathways and neural crest cell death in odd numbered rhombomeres (Farlie et al., 1999).
Further studies showed the importance of the “adjacent microenvironment” in
neural crest cells apoptosis. Blocking neural crest cells death in odd numbered
rhombomeres does not block or disrupt the segregation of neural crest cells. This finding
signifies the importance of the microenvironment adjacent to the neural tube in regulating
the path of neural crest cell migration (Golding et al., 2000). The influence or the effect of
the microenvironment is clearly evident from time-lapse imaging of neural crest cell
migration and lineage tracing in avian embryos. And this demonstrated that rhombomeres 3
and 5 do in fact produce neural crest cells. But the neural crest cells derived from these odd
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numbered rhombomeres migrate differently than the even numbered ones. Neural crest
cells originating from the odd numbered rhombomeres 3 and 5 migrate anteriorly and
posteriorly instead of laterally and they join the neural crest cell streams that originated
from even numbered rhombomeres. These data showed that the presence of neural crest
cell free zones and the segregation of the cells into discrete streams is not an intrinsic
property of the hindbrain and the odd rhombomeres in specific (Reviewed in Trainor et al.,
2003). These data also emphasize that the regulation of the pathways of neural crest cell
migration is influenced by the microenvironment adjacent to the neural tube.
Another notion that explains the segregation of the neural crest cells into the
distinct streams and the reciprocal transplantation of the cells between odd and even
numbered rhombomeres is that, the intrinsic or inter-rhombomeric signaling is less
important than the combinatorial interactions between the hindbrain and adjacent paraxial
tissue in the process of restricting the generationa and migration of neural crest cells. This
notion is supported by a study, in which ErbB2 null mutant mice were examined (Golding
et al., 2000). The group found that neural crest cells derived from rhombomere number 4,
acquire the ability to migrate through the dorsal mesenchyme adjacent to rhombomere
number 3. The expected cause of the aberrant migration is a group of changes in the
paraxial mesenchyme environment and is not autonomous to the neural crest cells. ErbB4
is normally expressed in the rhombomeres 3 and 5, so the observed phenotype reflects
defects in the signaling between the hindbrain and the adjacent microenvironment
(Reviewed in Trainor et al., 2003).
Despite of the mechanism that underlies the segregation of neural crest cells into
the distinct streams, this process has an importance in the separation of Hox-expressing
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neural crest cells and the non-Hox expressing neural crest cells. Hox are a group of genes
that specify the anterior-posterior axis in organisms during early embryonic development.
It also specifies segment identity. A study by Pasqualetti et al., (2000), in which the group
made full-length constructs derived from XHoxa2, mouse Hoxa2 and zebrafish Hoxa2.
They then injected full RNA’s into the blastomeres of two cell stage Xenopus embryos.
Specific alterations of the neural crest-derived skeleton of the pharyngeal arches were
observed. The group couldn’t find any differences between the different RNA’s (Xenopus,
mouse and zebrafish) indicating the conservation of the protein. The group finally found
that Hoxa2 induction at postmigratory stages results in mirror image transformation of a
subset of jaw elements, normally lacking Hox expression, towards hyoid morphology,
which is the reverse phenotype to that observed in the Hoxa2 knockout.
It was also shown that over-expression of Hoxa2 in the first branchial arch neural
crest cells, transforms and converts the identity of the first arch into that of a second arch
(Grammatopoulos et al., 2000). This will ultimately suppress jaw formation (Pasqualetti et
al., 2000). The reverse of this observation is seen in Hoxa2 null mice, in which the second
arch identity is transformed into a first arch identity, and that results in the duplication of
the first arch skeletal structures.
Cranial ganglia fusions were observed in a number of mouse mutations that resulted
in mixing of the neural crest streams. From this, we may conclude that the segregation of
the neural crest cells in their distinct streams is important for proper jaw formation and
normal head development.
Craniofacial Development & Patterning of Neural Crest Cells
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The experiment that showed when neural crest cells from the first arch were
transplanted posteriorly to the second or third arch lead to the formation of duplicate first
arch skeletal elements, put the basis for the classical view of craniofacial devekopment and
neural crest patterning. And this states that regional diversity in the vertebrate head was a
consequence of patterning information provided by the neural crest (Hunt et al., 1991).
These duplicated crest-derived structures were not only un-usual for their new location, but
connections, attachments and muscle cell type associated with these structures were also
typical of a first arch pattern (Reviewed in Trainor et al., 2003).
These data suggest many ideas that ultimately lead to the “neural crest preprogramming” model. The hypothesis is, that the neural crest cell fate must be programmed
prior to the emigration of the cells. Another hypothesis is, that the myogenic cell
populations or other cell types, receives signals from the migrating neural crest cellsconnective derivatives. For instance, most of the cranial neural crest cells arise from the
hindbrain, and it was found that the same restricted domains of the Hox gene expression
found in the hindbrain, also continues in the migrating cranial neural crest cells. And also
in their derivatives, thus reflecting the origins of the neural crest cells constituting the
tissues (Hunt et al., 1991). All these observations led to the neural crest cells preprogramming model, which said that positional information’s encoded by the Hox genes
were carried from the hindbrain to peripheral tissues and branchial arches by the neural
crest (Hunt et al., 1991).
New information emerged when more studies were done examining the plasticity of
neural crest cells and trying to understand the real mechanisms contributing to craniofacial
patterning. Especially with the studies that included neural crest cells transpositions within
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the hindbrains of the mouse. In study performed by Trainor & Krumlauf et al., 2000, the
group did a series of heterotopic transpositions of neural crest cells in which they grafted
rhombomeres 3, 4 or 5 cells in rhombomere 2. The group focused on the donor cells that
did not maintain their reporter gene expression and were dispersed in their new
environment. They found that, despite previous evidence for autonomy of gene expression
in rhombomeric tissue, the results showed that individual rhombomeric cells can show
plasticity with respect to Hox expression and they are able to change their fate. These data
indicate that cells in ectopic location, lack the signal from their normal neighbors to
maintain their identity and that the community that surrounds the cell has a very significant
effect too.
Another study that supported the idea of the importance of cell-community was
performed using zebrafish embryos. The transplanted cells were followed for longer
periods. Examining their gene expression, it was found that the cells activated new gene
expression programs and they differentiated and contributed to the pharyngeal cartilages
appropriate to their new axial location (Schilling et al., 2001).
The results that were obtained from the studies that involved transpositions of
neural crest cells in both mice and zebrafish hindbrains, contradicted the idea that said that
the axial character of neural crest cells is fixed or it is passively transferred from the
hindbrain to the pharyngeal arch’s and the periphery of the head. These studies proposed a
new model, which Trainor et al, called in his review “neural crest plasticity and
independent gene regulation model” as a mechanism for describing neural crest and
craniofacial development. But why this model was not seen in avian embryos, in which the
“pre-programmed neural cresl cells” model was strongly suggested, is because of the size
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and tissue that were used in the study and also timing effects. When whole hindbrains oe
rhombomeres are translplanted, signals between the rhombomeres or from neighbor cells
may cause re-inforcement of the cells identity of the transplanted cells. But in the studies
done on mice and zebrafish, only small rhombomeric cell populations or single cells were
transplanted. So graft derived migrating neural crest cells will be more likely to respond
better to the new environment in which they were transplanted. This makes the mice and
zebrafish studies more powerful and significant that the ones performed on avian embryos.

CHAPTER 2: Pathogenesis of Treacher Collins Syndrome

Identification of the TCOF1 gene

26
Using highly informative short tandem repeat polymorphisms and

positional

cloning, the Treacher Collins Syndrome Collaborative group (1996) identified a novel gene
of unknown function, which they designated TCOF1, within the TCS critical region,
between the RPS14 gene (proximal) and ANX6 gene (distal) on chromosome 5 (5q32 –
q33.1) (Dixon et al, 1993 and TCS collaborative group, 1996). The genomic sequence of
the gene was isolated and it was shown that it consists of 26 exons and encodes a low
complexity, serine/alanine - rich protein of approximately 144 kD called Treacle (Dixon et
al 1997). The deduced 1,411-amino acid protein has 3 conserved domains, including a
LisH (LIS1-homology) motif at the N- terminus (Emes and Ponting, 2001), followed by
alternate repeats of acidic and basic residues and multiple nuclear localizing signals and a
single nucleolar localizing signal at the C-terminus (figure 5). Indirect immunofluorescence
shows that treacle is localized to the nucleolus in Hela cells and fibroblasts from healthy
unaffected individuals (Isaac et al., 2000). The repetitive protein motifs are shared with
nucleolar trafficking proteins in other species and are predicted to be highly phosphorylated
by casein kinase II (Wise et al., 1997).
Databases sequence comparisons shows weak but significant homology between
treacle and Nopp140 which is a rat nucleolar phophoprotein. Like treacle, Nopp140, is a
low complexity protein which contains 10 repeat units of alternating acidic and basic
regions, with each repeat containing numerous casein kinase phospjorylation sites.
Northern blot analyses show that TCOF1 is expressed in nearly all adult and fetal
tissues in low levels. A 5.8 kb transcript was detected in adult heart, placenta, adult
pancreas, fetal and adult brain, lung, liver and kidney. In addition, an additional transcript
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of 6.3 kb was also detected in adult skeletal muscle (Treacher Collins Syndrome
Collaborative Group, 1996).
Mutations in TCOF1 gene
In 2004, Teber and collaborators performed a study in which they screened 46
patients with a clear clinical diagnosis of TCS. The patients were referred to the group
when they asked for TCS patients and in addition, the group re-examined the patients
clinically. These patients showed the typical clinical findings of TCS including downward
slanting palpebral fissures, lower eyelid coloboma, hypoplasia of the zygomatic complex
and mandible, and microtia. It was found that, 78% of the patients did carry heterozygous
mutations in TCOF1, including frameshift, splice donor or acceptor mutations and
nonsense mutations. The majority of these mutations were predicted to truncate treacle, and
this implies a potential importance of the C-terminal of the protein for its function. There
was no observed correlation between phenotype variability and the type of mutations
identified. It is also worth noting that 60% of TCS cases are due to de novo mutations
(Splendore et al., 2002). The mutations identified in unique families are different. But there
is an occurring 5 base pair deletion in the TCOF1 gene (TCOF1 mutations database,
www.genome.ib.usp.br/tcof1_database).
Ribosome Biogenesis
Ribosome biogenesis is the process of the formation of the constituents of the
ribosome subunits, their assembly, and their transport to the sites of protein synthesis. In
eukaryotes ribosome biogenesis occurs in the nucleolus, which is a specialized
compartment within the nucleus. The process begins with the synthesis of a large prerRNA transcript (Figure 5) by RNA polymerase I. This transcript then goes through a
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complex series of processing, modification and folding steps. This will ultimately lead to
the formation of the mature 18S, 5.8S and 25/28S ribosomal RNAs which will be
assembled into functional ribosomal subunits.
Eukaryotes have 80S ribosomes, each consisting of a small 40S and a large 60S
subunit. The large subunit is composed of a 5S RNA (120 nucleotides), a 28S RNA (4700
nucleotides), a 5.8S subunit (160 nucleotides) and ~49 proteins. The 40S subunit has a
1900 nucleotide (18S) RNA and ~33 proteins. These mature RNA components are released
from the pre-rRNA following a very complex maturation pathway. Pre-rRNA undergo a
number of modifications and are bound by ribosomal proteins before the assembled
pre-40S and pre-60S are exported separately to the cytoplasm (Reviewed in Venema and
Tollervey, et al 1999).
The complex process of maturation of ribosomal rRNA and its assembly into the
final eukaryotic ribosomal subunits involves at least 170 accessory proteins. These proteins
are exonucleases (an enzyme that cleaves nucleotides one at a time from the end of a
nucleotides chain), endonucleases (an enzyme that cut phosphodiester bonds between
nucleotides), RNA helicases (an enzyme that unwinds annealed nucleic acid strands) and
chaperones or assembly factors and almost as many small nucleolar ribonucleoprotein
particles (snoRNP’s) (Fromont-Racine et al., 2003).
The two major modifications of pre-rRNA, are methylation and pseudouridylation.
Both of these modifications depend largely on the snoRNA’s. There are two families of the
snoRNAs, box C/D antisense snoRNAs and ACA snoRNAs (Reviewed in Cavaille et al.,
1996). SnoRNAs of the first family contain two short sequence motifs, box C and box D,
and 10-21 nt sequences complementary to rRNA. A specific box C/D antisense snoRNA is
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associated with each methylated nucleotide in ribosomal RNA, which precisely targets the
position to be methylated in pre-rRNA through transient formation of a long duplex
structure at the modification site. The other family of snoRNA, is the ACA family. This
family is defined by the presence of a 3’ ACA sequence, which guides pseudouridylation at
a particular ribosomal RNA site through specific base pairing with ribosomal RNA.
In order to carry out the modifications, each snoRNA associates with at least four
protein molecules in the RNA/protein complex snoRNP. The proteins associated with each
RNA depend on the type of snoRNA molecule (C/D box member or ACA snoRNA). As
mentioned above, the snoRNA molecules contain an antisense element (about 10-20
nucleotides) which are base complementary to the sequence surrounding the nucleotide
targeted for modification in the pre-rRNA. This enables the snoRNP to recognize and bind
to the target RNA. Once the snoRNP has bound to the target site the associated proteins are
in the correct physical location to catalyze the chemical modification of the target base. It is
also worth noting that, the modifications of pre-rRNAs are important for the final threedimensional structure of the mature ribosome.

Figure 4: A schematic of pre-RNA, indicating the mature 18S (red), 5.8S (green) and
25/28S (blue) rRNAs which must be removed from the precursor. An ordered set of
cleavages remove the 5′ and 3′ external transcribed spacers (ETS) and the internal
transcribed spacers, ITS1 and ITS2.
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Peculis et al., 2005.
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Treacle Function
Treacle is classified as a nucleolar phosphoprotein due to the conserved acidic and
basic repeats and its localization to the nucleolus (Winokur and Shiang, 1998). Treacle is
also known to physically interact with upstream binding factor (UBF), which is a
transcription factor for RNA polymerase I, and hence may play a role in the transcription of
ribosomal DNA (Dixon et al, 2004). Examination of the cDNA-derived amino acid
sequence of the human treacle using the website http://motif.genome.ad.jp show 13 High
Mobility Group (HMG) DNA binding domains, which preferentially bind to the minor
groove of AT-rich regions in double-stranded DNA, distributed throughout the molecule
(Gonzales et al., 2005). Chromatin immunoprecipitation (ChIP) assay performed using
HeLa cells, showed that treacle binds to the 5’ external transcribed spacer 1 (ETS1) and to
promoter region of rDNA (Gonzales et al., 2005). The proposed model for the role of
treacle in the transcription of rDNA is that treacle binds to the ETS1 and to promoter
region of rDNA and this physically blocks RNA polymerase I from transcribing. This
happens in early mitosis when RNA polymerase I is shut down. In late telophase, treacle
interacts with UBF, and this promotes its dissociation from ETS1 and lead to the
transcription of rDNA (Valdez et al., 2004). Data obtained from the ChIP assays support
the proposed model. Treacle was shown to to bind to the promoter region of rDNA genes
and the ETS1 and was also shown to physically interact with UBF which is a part of the
transcription initiation complex. Additional experiments in which ChIP assays can be
performed, once when cells are blocked in early mitosis and again when cells are blocked
in early G1 phase, would be suitable to confirm the proposed model.
A study performed by Valdez et al., (2004), showed the importance of treacle
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binding to the promoter region of the ribosomal genes. Short interference RNA (siRNA)
that targets the 5’ end of exon 3 of TCOF1 mRNA was used to downregulate gene
expression. The level of rDNA transcription was examined using ³²P- labeled antisense
riboprobe that binds to the 5’ end of pre-rRNA. It was found that Hela cells that were
treated with the siRNA that targeted TCOF1 gene, showed 47% decreased production of
pre-rRNA compared to the control (unrelated siRNA). To test this finding in an in vivo
model, the level of transcription of rDNA in heterozygote Tcof1+/- mouse embryos was
examined. Embryos from DBA x C57BL/6 cross were genotyped and the level of Tcof1
was determined by RT-PCR to identify heterozygotes. RNA samples of Tcof1+/- embryos
were examined using ³²P- labeled antisense riboprobes that binds to the 5’ end of pre-rRNA
and it was found that, in the Tcof1+/- mice, the production of pre-rRNA was reduced
compared to wild type mouse embryos. Reduced pre-rRNA production is observed in both
in vivo and in vitro models when Tcof1 is decreased. These findings suggest that
insufficient treacle levels will lead to the absence of its binding to the promoter region of
ribosomal genes. Therefore, there will be less of UBF in the transcription preinitiation
complex, and ultimately reduced transcription.
Treacle was also found to interact with selectivity factor I (SL1), which binds to the
promoter region of rDNA genes to position RNA polymerase I properly and acts as a
channel for regulatory signals in the nucleolus (Valdez et al, 2004). This might be due to co
localization of both SL1 and TCOF1 on promoter regions of rDNA. Treacle was also found
to interact with Nop56p, a component of the ribonucleoprotein (RNP) complex that
mediates the 2’-O-methylation of pre-ribosomal RNA during early stages of pre-rRNA
processing (Hayano et al, 2003).
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These data imply that treacle is also a part of an RNP complex in the nucleolus and may be
specifically involved in governing the ribosome biogenesis process which is important for
normal cell growth and proliferation. This is also supported by the fact that treacle shares a
significant homology with Nopp140, which also associates with RNA polymerase I and
leads to decreased rRNA production if inhibited (Hung-Kai et al, 1999). Mice that were
haploinsufficient for Tcof1, exhibited diminished mature ribosome production as measured
by the levels of 28S rRNA. This deficiency was observed in the neural ectoderm as well as
in the neural crest but not in tissues such as the endoderm implying that treacle may
function as a tissue-specific regulator of ribosome biogenesis (Dixon et al, 2006). From
these findings, Treacle is thought to link RNA polymerase I-catalyzed transcription and
post- translational modification of pre-rRNA.
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Figure 5: Treacle with three conserved domains: LisH (Lissencephal-Homology), 10
repeats of acidic and basic residues and multiple nuclear localizing signals (NLS) and a
nucleolar localizing signal (NoLS).
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Underlying Cause of Phenotype of TCS
Mouse model of TCS has been extensively used in studies to understand the
developmental abnormality associated with the disease. The tissues that are affected in
Tcof1 mutant mouse embryos are derived entirely or in part from neural crest cells. The
underlying cause of these observed craniofacial anomalies in the Tcof1 knockout mouse
embryos is an increase in apoptosis in the neuroepithelium (Dixon et al., 2005). The
neuroepithelium is present prior to the onset of neural crest cells induction, which occurs
around embryonic day 8 (E8) and continues until E9 and E10. This overlaps with the
period of neural crest cells induction and migration during mouse embryogenesis (Poswillo
et al., 1975).
At the same time, studies performed on Tcof1 +/- mice showed that neural crest
cells migration was not hindered as a separate process. This leads to the conclusion or the
hypothesis that the facial abnormalities characteristic of Treacher Collins Syndrome appear
to arise due to problems that originate within the neural plate. Excessive neuroepithelial
apoptosis is likely to result in a reduced number of neural crest cells that migrate into the
frontnasal region and pharyngeal arches.
Consequently it has been hypothesized that deficient ribosome biogenesis is
incapable of meeting the cellular and metabolic needs of the highly proliferative cell
populations in the neural ectoderm and neural crest during embryogenesis and more
specifically it is directly responsible for the high levels of cell death observed in these cell
populations at the time of formation. Insufficient ribosome biogenesis leading to increased
neuroepithelial apoptosis and deficient formation of migrating cranial neural crest cells is
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causing the hypopasia of cranioskeletal elements in TCS, because the majority of bones,
cartilages and connective tissues in the head and face are derived from neural crest cells.

Identification of The Apoptosis Pathway of TCS
Infants with TCS that have severe hypoplasia of the mandible and zygomatic
complex typically have cleft palate along with narrowed airways and consequently
experience major breathing and feeding problems (Reviewed in Trainor et al, 2008). In
most cases new born infants require immediate tracheostomy. Repairing the phenotype of
TCS

require

the

collaborative

work

of

craniofacial

surgeons,

orthodontists,

ophthalmologists, otolaryngologists and speech pathologists. Still the results remain
variable and not fully corrective (reviewed in Sakai et al, 2008).
A recent study has shown that the protein p53 is found to be activated and
stabilized in the neuroepithelium of Tcof1 heterozygote mutant mouse embryo, along with
other p53 responsive pro-apoptotic proteins. A genome wide expression analyses of E8.5
Tcof1 +/- mice embryos was compared to wild type mice of the same age by microarray
analysis (Jones et al., 2008). As was mentioned above, the increase in neuroepithelium
apoptosis that occurs in Tcof1 heterozygote mice, happens at around E8. For that reason,
the group decided to look at gene expression at this time point. It is worth mentioning that
the Tcof1 heterozygote knockout mice used in the study, had a reduction of Tcof1 of about
40%.
A number of genes were found to be upregulated in the Tcof1 +/- mice as compared
to the wild type. One of the genes was the Ccng1, which encodes cyclin G1, which is a p53
responsive gene that inhibits growth and arrests cells in the G1 phase of the cell cycle.
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Another gene that was also found to be upregulated was Noxa, which is a member of the
Bcl2 family and is known to be important in mitochondrial fragmentation and caspase
activation. Both of these genes and many more that were found to be differentially
expressed in the Tcof1 +/- mutant mouse embryo epithelium, are known recognized targets
and mediators of p53-dependent transcription. But, p53 itself was not found to be
upregulated.
Therefore the level of the protein that the gene p53 encodes was examined.
Normally, p53 protein is readily degraded and has a short half life of about 20-30 minutes
and is thus usually maintained in very small and often undetectable levels. As expected, the
ummunoblot analysis showed an increased level (2.28 fold) of p53 protein in the E10.5
Tcof1 +/- embryos than in their wild type littermates.
This finding indicates that there is a post-translational control of the level of p53
protein. But in order to prove the link between the increased levels of p53 and the apoptosis
seen in the neuroepithelium, immunostaning of embryos of the age of 8.5-9.5 with antibody
specific to p53 was performed. While the expression was barely detectable in the wild type
embryos, in the Tcof1 +/- embryos, increased level of staining was confined to the
neuroepithilium. Further quantification of the intensity of the signal showed that there is an
increase of about 1.8 fold. Even when counterstained with DAPI, the p53 signal was
showed to be restricted to the nuclei of the neuroepithelium. This also supports the
hypothesis that, increased apoptosis in the epithelium results in reduced migration of neural
crest cells.
After confirming the stabilization of p53 in the neuroepithelium, the potential of
being able to prevent the onset of TCS with the inhibition of p53 was investigated. Pifithrin
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was used, which is a known inhibitor of p53 that inhibits its binding Bcl-xl and Bcl2
proteins. Pregnant mice were given pifithrin-alpha once daily starting from E6 to E8.5. The
timing here is very important because at this time point, the neuroepithelial apoptosis
occurs in the Tcof1 +/- embryos. Control pregnant females were given PBS. Embryos were
collected at age E8.5 which coincides with the formation and migration of neural crest
cells, and these embryos were assayed for apoptosis by TUNEL (Terminal
Deoxynucleotidyl Transferase dUTP Nick End Labelling), which is a technique used to
detect DNA fragmentation as a result of apoptosis. In 67% of Tcof1 +/- embryos that were
treated with pifithrin-alpha, neuroepithelium apoptosis was substantially reduced, as
compared to the Tcof1 +/- embryos that were not treated or the ones that were given PBS.
Then an attempt to rescue the phenotype by inhibiting p53 genetically was
performed. The progeny of the intercrosses of Tcof1 +/- and p53 +/- mice were assayed for
apoptosis at E8.5 using antibody specific to caspase-3. It was found that the loss of one
copy of the p53 gene, resulted in reduced amount of neuroepithelial apoptosis in the Tcof1
+/- embryos as compared to the Tcof1 +/- embryos with wild type p53. Furthermore, the
loss of the two copies of p53, abrogated caspase-3 activity as compared to only copy being
missing. The mice that resulted from these matings looked normal and the phenotype was
successfully rescued. But after 6 months, a number of p53 -/- mice developed tumors and
had to be sacrificed. This is the major caveat with this rescue. Previously it has been well
established that p53 is a tumor suppressor gene that functions in cell cycle arrest regulation,
detection of DNA damage, centromere amplification and apoptosis (Haupt et al, 2003). So
it is expected that losing a copy or both of this gene may have a significant effect on the
organism.
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The p53 protein is known to get activated and stabilized through the inhibition of a
protein called Mdm2 (or HDM2 in humans). HDM2 is found to be amplified in a number
of human sarcomas (Oliner et al., 1992). The inhibition of p53 by HDM2 is achieved by
either the direct binding of HDM2 to p53 or by the E3 ligase activity of HDM2 that can
target p53 for ubiquitination (Fang et al., 2000). The ubiquitination of p53 by HDM2
contributes to the proteasomal degradation of p53 and also to the export of p53 from the
nucleus to the cytoplasm (Haupt et al., 1997). p53 is a transcription factor that induces
expression of many genes that mediate the apoptotic and cell cycle arrest response to p53
induction (Vousden and Lu, 2002). Importantly, p53 can also activate transcription of
HDM2, establishing a regulatory loop in which p53 induces expression of its own negative
regulator. Stress-induced activation of p53 depends in part on the inactivation of HDM2
and the inhibition of HDM2-mediated ubiquitination of the p53 protein. The inhibition of
HDM2 can be achieved through several mechanisms, with different stress signals utilizing
different pathways to allow stabilization of p53.
Defective ribosome biogenesis is known to cause what is called a nucleolar stress.
Nucleolar stress was found to activate a p53 dependent check point and subsequent cell
cycle arrest and apoptosis (Pestov et al, 2001). It was also reported that, when the
biogenesis of ribosomes is impaired, this promotes the release or the diffusion of a number
of 60S ribosomal proteins into the nucleoplasm. Specifically, a ribosomal protein called
L11 (Lohrum et al., 2003). Coexpression of L11 with HDM2 and p53 in an in vitro system,
prevented degradation of p53 in a manner similar to that seen following ARF expression,
which is a protein known to bind HDM2’s ubiquitin ligase active site (Lohurm et al.,
2003). Furthermore, in U2OS cells, which express wild type p53 and HDM2, but no ARF,
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elevation of endogenous p53 and HDM2 levels was seen following L11 expression. In the
same study, HDM2 was found to localize with L11. These findings were replicated after
the use of actinomycin-D, which selectively inhibit the activity of RNA polymerase I (the
polymerase responsible for rDNA transcription). In addition, flow cytometric analysis of
L11 transfected cells showed that expression of L11 and stabilization of p53 led to a G1
arrest, which was also seen in neuroblastoma cell lines, in which the TCOF1 expression
was knocked down (Lin et al., 2004).
The hypothesis is, when Tcof1 gene is mutated and there is less functioning Treacle
being produced leads to reduced levels of rDNA transcription, and also to abnormal
processing of pre-rRNA. The decrease in ribosome biogenesis, results in the diffusion of a
number of ribosomal proteins like L11 or L23 (Dai M.S et al., 2004) into the nucleoplasm.
L11 or L23, inhibit HDM2 by binding to its ubiquitin ligase active site and thus, preventing
its proteosome mediated degredation of p53. Therefore, the protein p53 gets stabilized and
activated. A number of p53 targets are activated which leads to cellular arrest in the G1
phase and ultimately apoptosis. These are the predicted event that leads to the increase in
apoptosis that was reported to be seen in the neuroepithelium of Tcof1 +/- mouse embryos.
The best attempt to prevent the onset of TCS was the inhibition of p53 in Tcof1 +/mouse embryos (Dixon et al., 2008) but this resulted in tumor formation which, limits the
potential of using this method for treating TCS in humans. Thus, the importance of
identifying the apoptosis pathway in TCS is evident. Finding a downstream effector of p53dependent apoptosis that was not linked to cancer or tumor progression, as a potential
minimal risk candidate for the therapeutic prevention of TCS can be promising.
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A genome wide analysis was performed in which the genes that were differentially
expressed with TCOF1 being knockdown or overexpressed were investigated in mouse
neuroblastoma cell line (Mogass et al., 2004). A number of genes were found to be
coordinately regulated with Tcof1; one of the most significant ones was the T-box2 (Tbx2)
which had a log2 fold change of 1.56. Tbx2 is a known transcriptional repressor and it
specifically regulates p19 in mouse embryo fibroblasts (Jacobs et al., 2000). It is known
that the activation of p19 promotes the stabilization of p53 by inhibiting the E3 ligase
activity of Mdm2. Interestingly, p19 expression was found to be negatively correlated with
the expression of Tcof1 and Tbx2. But in the Tcof1 knockdown cell line, in which Tbx2
expression is decreased, p19 was not found to be activated.
Two other genes were found to be negatively correlated with Tcof1 expression are,
Bnip3 and Binp3l. These proteins are known pro-apoptotic proteins (Imazu et al., 1999;
Chen et al., 1997). Thus, the reduction in Tcof1 may reduce the ability of a cell to
synthesize proteins due to reduced mature ribosome production, and this could activate an
apoptotic response through Bnip3 or Bnip3l. As was mentioned before, phenotype seen in
TCS is caused by increased p53-mediated apoptosis in the neuroepithelium, interestingly,
Bnip3l is a direct transcriptional target of p53 (Fei et al., 2004), which makes Bnip3l a
strong candidate for being a downstream gene in the p53 apoptotsis pathway.
Another gene that is strongly regulated by the Tbx2, is Cyclin-dependent kinase
inhibitor 1A (p21), also known as CDKN1A. Tbx2 acts as a transcriptional repressor of
p21 (S Prince et al., 2004). P21 is also one the main transcriptional targets of p53, which
was shown to be stabilized in the Tcof1 heterozygote mouse embryos (Dixon et al., 2008).
P21 protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety
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of stress stimuli. Hence, it is possible that, like in DNA damage response, p21 causes G1
arrest when Tcof1 is decreased and there is deficient ribosome production. And as was
mentioned above, p53 is affected by the nucleolar stress caused by deficient ribosome
biogenesis, and this is by the inhibition of Hdm2 by L11binding to it’s ubiquitin ligase
active site (Lohurm et al., 2003). In an experiment that aimed to investigate the role of p21
in regulating the apoptosis/ autophagy switch, mouse embryonic fibroblasts that were p21
+/+ were compared to p21 -/- MEF’s, when both were treated with ceramide to induce cell
death and it was found that p21 always turned off the autophagy pathway and promoted
apoptosis (Fujiwara el at., 2008). In the same experiment, when Z-VAD-FMK was used,
which is a caspase inhibitor with broad specifity, it inhibited p21 apoptosis in MEF’s.
In the literature, p21 is reported to promotes apoptosis in response to a variety of
stimuli and in different systems. Overexpression of p21 in thymocytes led to
hypersensitivity to p53-dependent cell death in response to ionizing radiation and UV but
not to dexamethasone in transgenic animals (Fotedar et al., 1999). Overexpression of p21
in C3 SV40 T-antigen mammary tumor cells deficient for p53 activity increased apoptosis
(Shibata et al., 2001). Overexpression of p21 has been shown to enhance the apoptotic
response to the chemotherapeutic agent cisplatin in glioma and ovarian carcinoma cell lines
(Condo et al., 1996) (Lincet et al., 2000). It is also worth noting that p21 was also reported
to negatively regulate p53-dependant apoptosis in certain systems (Fujiwara et al., 2008).
As was mentioned above, the cells that undergo apoptosis in TCS are arrested in the
G1 phase. Other than p21, the Cyclin-dependent kinase inhibitor 1B (p27, Kip1), also
known as CDKN1B, also controls G1-S phase transition. The p27 gene has a DNA
sequence similar to other members of the "Cip/Kip" family which include the p21 and p57
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genes. In addition to this structural similarity the "Cip/Kip" proteins share the functional
characteristic of being able to bind several different classes of Cyclin and Cdk molecules.
For example, p27 binds to cyclin D either alone, or when complexed to its catalytic subunit
CDK4. In doing so, p27 inhibits the catalytic activity of Cdk4, which means that it prevents
Cdk4 from adding phosphate residues to its principal substrate, the retinoblastoma (pRb)
protein. Increased levels of the p27 protein typically cause cells to arrest in the G1 phase of
the cell cycle. Therefore, p27 may be causing the G1 arrest that precedes apoptosis in TCS.

CHAPTER 3: Animal Models of Treacher Collins Syndrome
Animal models are very important and useful in studying human diseases and
identifying potential treatments. There is a wide variety of model organisms used in
scientific research today, especially when human experimentation would be unfeasible or
unethical. Selecting the appropriate model that would serve the study best is very crucial.
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For a model to be usable to study TCS it has to have a similar head development and is
easily studied. Homologs of TCOF1 have been identified in mouse (Jabs et al., 1993), dog
(Haworth et al., 2001), frog (Gonzales et al., 2005) and rhesus macaque (Shows et al.,
2006).
Identification of Canine TCOF1
It is thought that the majority of modern dog breeds have been generated over the
past 250 years. This suggests that only a small number of loci are controlling most of the
phenotypic differences (Ostrander et al., 2000). Such a characteristic makes the dog an
excellent model system to study the molecular genetics of morphological traits (Haworth et
al., 2001).
Canine TCOF1 is 4814 bp long and shares 80% identity with the human sequence.
Dog TCOF1 does not posses an equivalent of exon 10, but contains an extra sequence of
252 bp between exons 16 and 17.
The protein coded for by the dog TCOF1 gene was found to share a significant
homology (71%) with the human’s protein (Haworth et al., 2001). It is 28% serine and
alanine, exactly like humans. Both the C- and the N- termini are well conserved, sharing
73% and 81% homology respectively. In dogs TCOF1 was found to be expressed in
neonatal brain, heart, kidney, liver, spine and muscles.
Identification of Frog TCOF1
Homologies between mammals and amphibians TCOF1 was found to be low. For
example, mouse Tcof1 shares 56% and 20% homology with human and frog TCOF1
(Gonzales et al., 2005). In contrast, their amino acid compositions are similar in terms of
predominant amino acid residues which include alanine (11–15%), glycine (4–8%),
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glutamic acid (7–10%), lysine (11–14%), proline (9–11%), serine (13–15%) and threonine
(7–8%). Like human, dogs and mice, Xenopus Laevis treacle have an N-terminus rich in
serine and lysine residues and a C-terminus rich in lysine residues. Close to the center of
the molecule, there are 11 repeating units of alternating basic and acidic domains.
To determine the localization of frog treacle, encoded by the cloned Xenopus
cDNA, an antibody against amino acids 1–307 was generated in chicken. Indirect
immunofluorescence staining shows the antigen recognized by this antibody co-localizes
with nucleolin in the nucleolus of Xenopus Laevis kidney A6 cells (Gonzales et al., 2005).
Western blot analysis showed that protein is 160 KD.
Because of the localization of treacle to the nucleolus, it was thought that it may
have a function in ribosome biogenesis. The cDNA that encodes the Xenopus laevis
orthologue of TCOF1 was cloned to construct antisense oligodeoxynucleotides, which
decreased the Xenopus TCOF1expression to various levels when microinjected
individually into Xenopus oocytes. The effect of treacle down-regulation on the 2’-Omethylation of nucleotide C427 of pre-18S rRNA from Xenopus oocytes was examined. It
was found that down-regulation of treacle results in decreased methylation of pre-18S. It is
worth noting that, this was also observed in Tcof1+/- mouse embryos on the DBAxCBA
background which exhibit a lethal phenotype, but it was not observed in Tcof1+/- mouse
embryos on the DBAxBALB/c background, which show milder phenotypes. This suggests
that hypomethylation of pre-rRNA’s might be contributing to the differences in phenotype
between these backgrounds.

Murine Model
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The mouse Tcof1gene is located on chromosome 18 (Jabs et al., 1993). It has a
transcript of 4,013 bp, and 1,320 amino acids. It has 74.3% nucleotide identity, 61.5%
protein identity and 71% similarity to human gene (Dixon et al., 1997). The homology
between the gene in humans and in mice is greatest in the C- and in the N-terminal regions
of the proteins. The repetitive region is less homologous with the exception of the potential
CKII phophorylation sites which are well conserved (Dixon et al., 1997; Paznekas et al.,
1997). The predicted NLSs at the C-terminus are also well conserved.
Deletion of the Tcof1 gene in different backgrounds in mice showed variation in
phenotype (figure 6). Although penetrance of genetic mutations underlying Treacher
Collins Syndrome is known to be very high, inter and intra-familial variations exist (Dixon
et al., 1994). In severe cases, TCS patients die perinataly due to a compromised airway
(Edwards et al., 1996). On the other hand, some individuals are so mildly affected that it
can be extremely difficult to establish an unequivocal clinical diagnosis.
In fact, it is not unusual for mildly affected TCS patients to be diagnosed
retrospectively. This usually is brought by the birth of a more severely affected child. This
suggests that there are more TCS cases than what has been documented, but due to mild
phenotypes, they went undiagnosed. This variation could be due to genetic background,
and/or environmental factors.
Chimeric mice that carry a deletion of exon 1 of murine orthologue of TCOF1 have
been generated (Dixon et al., 2000). Breeding of male chimeras with female C57BL/6 mice
generated heterozygous offspring that exhibited several features that resembled the human
disorder. These embryos have hypoplasia of the mandible and abnormalities of the maxilla
(Dixon et al., 2000). But additional features of the phenotype that were not observed in
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TCS patients were also observed in these embryos, including absence of the eyes and nasal
passages and neural tube defects resulting in exencephaly.
It has been hypothesized that these features may be due either to species-specific
differences in the function of the human and murine genes or that the severity of the Tcof1
phenotype depends on the presence of modifying loci elsewhere in the genome.
Interestingly, although traditional heterozygous Tcof1 KO mice die perinatally on
the 129/B6 background, conditional KO in which Tcof1 is knocked out in neural crest cells
are phenotypically normal (Lin Li et al., 2006). One explanation is that other cell
populations are also important for craniofacial development. These cell populations may
expand and compensate for the loss of neural crest cells.
On a variety of backgrounds, Tcof1+/- embryos were examined by gross
morphologic, histologic and skeletal analyses at different ages, from embryonic day 8.5
(E8.5) to birth. Each of the different backgrounds or strains that were used generated Tcof1
+/- embryos that exhibited a highly reproducible, strain dependant phenotype (Figure )
(Dixon et al., 2004). The lethality of Tcof1+/- mice derived from the C57BL/6 has been
reported (Dixon et al., 2000). In addition, Tcof1+/- mice derived from CBA or C3H
backgrounds exhibited a lethal phenotype with perinatal death resulting from severe
abnormalities of the nasal complex and neural tube defects that resulted in exencephaly. On
the other hand Tcof1+/- mice derived from the backgrounds DBA/1 and BALB/c were
viable and rarely exhibited exencephaly (Dixon et al., 2004).
Analysis of CBA Tcof1+/- mice embryos showed that this strain exhibit a phenotype
that very much resembles that of the C57BL/6 strain. Gross morphologic characterization
showed that both C57BL/6 and CBA- derived Tcof1+/- embryos exhibited a developmental
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delay of about 0.5 to one gestational day when compared to wild type embryos (Dixon and
Dixon et al., 2004).
In addition, exencephaly of the forebrain and the midbrain is another feature
in common between the two strains. It was present in all C57BL/6 Tcof1+/- embryos and in
the vast majority of CBA Tcof1+/- embryos (Dixon and Dixon et al., 2004). Ocular
development was also comparable in the two strains. Anophthalmia (absence of the eyes)
was observed in all C57BL/6 Tcof1+/- embryos. In CBA Tcof1+/- embryos there was either
anophthalmia or microphthalmia.
Interestingly, skeletal analyses revealed a distinct difference between the two
strains. While Tcof1+/- embryos derived from C57BL/6 and CBA backgrounds showed
many common abnormalities of the craniofacial and axial skeleton, the CBA Tcof1+/embryos showed an extra feature, these embryos had delayed ossification of long bones
and absence of primary center of ossification (Dixon and Dixon 2004). And this feature
was not present in Tcof1+/- embryos derived from the C57BL/6 background. Both strains
were also shown to display absence of the bones compromising the frontal, parietal,
interparietal and supraoccipital bones.
Figure 6: Gross morphologic appearance of embryonic day 14.5 wild-type (A) and Tcof1
heterozygous (Tcof1+/-) embryos derived from different inbred strains as indicated. B-C:
DBA/1- and BALB/c-derived Tcof1+/- embryos did not exhibit any gross morphologic
abnormalities. D-F: Majority of C3H, C57BL/6, and CBA Tcof1+/- embryos exhibited
exencephaly. This deformity involved the forebrain and midbrain in the C3H and CBA
Tcof1+/- embryos and the midbrain in C57BL/6 Tcof1+/- embryos. In addition, C57BL/6 and
CBA Tcof1+/- embryos exhibited developmental delay and mid-facial hypoplasia.
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Dixon and Dixon et al., 2004.

The nasal complex development is poor in Tcof1+/- embryos derived from both
strains (Dixon and Dixon et al., 2004). A center cartilaginous mass replaced the nasal
spectrum, with no signs of nasal passages or olfactory sensory structures. Another skeletal
abnormality seen in both strains is the fusion of the inter-costal cartilages and ribs. Several
abnormalities in the form of fusions of cervical and thoracic vertebrae and digit anomalies
(polydactyly) were also reported to be seen in both strains (Dixon and Dixon et al., 2004).
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Exencephaly was also seen in Tcof1+/- embryos on the C3H background. Twenty
nine Tcof1+/- embryos on the C3H background were examined three had fully formed
cranial vaults and the remaining 26 exhibited exencephaly of the forebrain and midbrain
with well formed distinct telencephalic vesicles that protruded through the open neural tube
(Dixon and Dixon et al., 2004). Overall body size of the Tcof1+/- C3H mice was
comparable to their wild type littermates. Histological sections showed development of the
eyes, although they are compressed and abnormally shaped. In contrast to the C57BL/6 and
CBA Tcof1+/- embryos, skeletal analysis showed that C3H Tcof1+/- embryos had welldeveloped nasal passages.
DBA/1 Tcof1+/- embryos showed a moderate craniofacial phenotype. Six out of 48
Tcof1+/- embryos that were examined displayed exencephaly mainly of the midbrain and to
a lesser extent the forebrain (Dixon and Dixon et al., 2004). Hypoplasia of the mandible
was also present in these exencephalic embryos. But in the rest of the DBA/1 Tcof1+/embryos appeared normal and were indistinguishable from their wild type littermates.
These non-exencephalic DBA/1 Tcof1+/- embryos are viable, fertile and have a normal life
span. Similar to the DBA/1 Tcof1+/- embryos, BALB/c Tcof1+/- were indistinguishable from
their wild type littermates. Except for six embryos out of seventy-six who showed
exencephaly (Dixon and Dixon et al., 2004).
Cross breeding C57BL/ x 129 genetic backgrounds showed a very close phenotype
to TCS. These Tcof1 +/- embryos had abnormal maxilla and mandible but they also
exhibited anophthalmia and exencephaly, which caused perinatal death (Dixon et al.,
2002). This obstacle was resolved by crossing DBA Tcof1+/- mice to C57BL/6 wild type
animals (Dixon et al., 2006).
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So variation of phenotype in Tcof1 knockout mice on the different backgrounds
ranges from severe craniofacial defects and neonatal lethality in C57BL/6 (B6) or CBA/Ca
and 129 mixed backgrounds to majority phenotypically normal in BALB/c or DBA/1 and
129 mixed backgreounds. Partial elimination of Tcof1 gene in mouse in a mixed C57BL/6 /
129 background is neonatal lethal, which circumvent further detailed analysis of the
heterozygous and homozygous knockout mice on a hemogenous background. A
conditional knockout mouse model, which might more closely resemble human TCS
phenotype, was generated using the Cre-lox system (Lin Li et al., 2006).
Conventional knockout method results in the inactivation of the targeted gene in all
tissues and development stages in mouse. In contrast, conditional gene targeting
approaches were developed to generate time or tissue-specific knockout of the targeted
gene. The conditional knockout system can be very useful in studying TCS, to overcome
that fact that conventional knockout mice are embryonic or neonatal lethal which prevents
further detailed analysis. In addition, control of gene targeting in a time dependant manner
allows the analysis of gene function at different developmental stages. Also, the inhibition
of gene expression in certain tissues, may give more information about the specific
function of that gene in that certain tissue.
Previous traditional Tcof1 knockouts were generated by replacing exon 1 with
neomycin-resistance cassette, which showed that elimination of exon 1 is sufficient for
disrupting the gene expression (Dixon et al., 2000). A tissue specific knockout mouse
model was generated by the Cre-lox system (Lin Li et al., 2006). Knockout mice were
generated with two loxP sites flanking exon 1 of Tcof1 (floxed allele) and then crossed to
commercially available transgenic mice that express Cre recombinase under the control of

52
the Wnt1 promoter. Wnt1 is expressed in the central nervous system and early neural crest
cells progenitors (Echelard et al., 1994, Dorsky et al., 1998).
Due to the major effect that background has on the Tcof1 knockout mice, Wnt1-Cre
transgenic mice were transferred to a B6 background from its orginal Swiss-Webster
background. After the background transfer, homozygous floxed Tcof1 mice were mated
with Wnt1-Cre mice to generate conditional heterozygous knockout mice (Tcof1c+/-).
Unexpectedly, the Tcof1c+/- mice are viable, fertile, of normal size and display no physical
or behavioral abnormalities (Lin Li et al., 2006). This finding suggests that the expression
of Tcof1 in other tissue/cells or at an earlier time is important for mouse craniofacial
development.
Tcof1c+/- that were generated previously (Lin Li et al., 2006) were then mated to
homozygous floxed Tcof1 mice to generate conditional homozygous knockout mice
(Tcof1c-/-). Embryos were dissected at different embryonic days, because no pups were
identified at birth. It was found that the morphology of the Tcof1c-/- is indistinguishable
from Tcof1c+/- and wild type littermates on embryonic day 8 to 9.5. At E10.5, the Tcof1c-/displayed smaller first and second branchial archs compared to controls. The telencephalon
appeared larger in homozygotes than controls, which maybe a secondary change due to
defects in the branchial archs. Defects in craniofacial development started to appear with
exencephaly of the forebrain from E11.5 to E13.5. The maxillary and mandible are
severely underdeveloped.
Homozygotes start to die at E12.5, and this is thought to be caused by increased
abnormality of blood vessels (Lin Li et al., 2006). There was increased blood vessels
disruption in the cranial region and often these vessels were abnormally enlarged.
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Cartilage development was also assessed in the conditional homozygous Tcof1
knockout by staining with alician blue (Lin Li et al., 2006). The majority of Meckel’s
cartilage, which is derived from the first branchial arch and provides the template for
mandible development, is not found in the mandible while a portion persists in the malleus
and incus middle ear ossicles. Later at 13.5, other cartilages in the head region started to
develop in all controls but only in some of the homozygotes. Limb and spinal cartilages
were found not to be affected. The manner that cartilages derived from 1st and 2nd branchial
archs were affected, suggests that Tcof1 is essential for these cartilages development.
Although the mouse model can provide a very informative model to study craniofacial
diseases due to the similarities with humans, but it is time consuming, expensive and
requires a lot of maintenance.

Zebrafish (Danio Rerio) Model
Zebrafish serves as an excellent model for vertebrate developmental studies (Jones
and Huffman 1957). The landmark study that aimed to understand the development on
zebrafish was performed in 1938 by Roosen-Runge, and it followed the development of the
zebrafish embryo from fertilization to hatching, they reported intercellular movements, and
documented minute changes in cell diameter, viscosity, and surface tension (Vascotto et al.,
1997).
The zebrafish model provides many advantages in the study of early embryonic
development including high fecundity, external and rapid development, transparency of
embryos, low cost and the ability to knockdown genes of interest. The evolution of the
head is conserved among vertebrates. Humans and zebrafish diverged ~ 420 million years
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ago, yet both form the same skeletal cell types, including the neural crest cells (Hall and
Hanken., 1985).
Currently, zebrafish is considered an established model for studying craniofacial
development with several well characterized mutant lines readily available. Some mutant
lines display craniofacial defects related to those seen in TCS patients. Among those are
the forkhead box 3 (foxd3), transcription factor ap-2 alpha (tfap2a) and sox9a. Even the
mechanism of formation of the phenotype in the fox3d mutants is similar to the tcof1
mutants. It is mainly due to failure of a subset of neural crest cells derivatives to undergo
specification and normal migration (Stewart et al., 2006). Similarly, tcof1 is required of
survival and migration of certain neural crest cells to the pharyngeal arches in mice (Dixon
et al., 2000).

Early developmental stages of zebrafish
For a full understanding of the pathogenesis of any developmental disorder, it is
important to understand the early stages of development. The major important stages of the
early development of zebrafish embryo include: the zygote formation, cleavage, blastula,
gastrulation, segmentation, pharyngula and hatching stages (Kimmel et al., 1995).
The zebrafish zygote is about 0.7 mm in size and this stage starts with the
fertilization of the egg and extends for about 40 minutes. The zygote stage is also defined
by the formation of what is called the blastodisc, which forms by the migration of
cytoplasm toward the animal pole. After the first cleavage the cells starts dividing at about
15 minutes intervals, defining the second stage which is the cleavage stage (Figure 7). In
this stage there is synchrony in cell division to the 64 cell stage where a 3 tier blastomere is
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formed. This is between 40 minutes to 2 hours post fertilization (hpf) (Kimmel et al.,
1995). After that the blastula stage starts, which is marked by the formation of the yolk
syncytial layer (YSL). This layer is the result of the fusion between the marginal
blastomere and the yolk cells.
The nuclei of the YSL continue dividing but are not accompanied by cytoplasmic
division. In the beginning of the late blastula, epiboly starts, this is the thinning and
spreading of both the YSL and the blastodisc over the yolk cell. About a third of epiboly is
completed around 4 hours and 40 minutes post fertilization.
In the gastrula stage epiboly continues, reaching 75% around 8 hpf (Figure 8). In
addition, the morphogenetic cell movements of involution, convergence, and extension
occur, producing the primary germ layers and the embryonic axis (Kimmel et al., 1995).
Gastrulation ends at around 10 hpf and after that the embryo develops complete epiboly
and has prominent tail bud and ealy polster. Polster is the hatching gland rudiment at the
time it underlies the forebrain during the early segmentation period (Kimmel et al., 1995).
The segmentation stage lasts from 10 1/3 hpf to 24 hpf. In this stage the tail bud
becomes prominent, the rudiments of primary organs become visible and the embryo
elongates. By 48 hours, fins start forming, the otic vesicles also develop and the yolk size
decreased as the size of the head increase.
Neural crest cells that are bound to form cartilage begin chondrification. Features of
lower jaw appear. By 72 hours, the organs are almost completely formed, including jaw,
gills and fins.
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Figure 7: Embryos during the cleavage period. Face views, except for B, which shows the
embryo twisted about the animal-vegetal axis, roughly 45" from the face view.
A: Two-cell stage (0.75 h). B: Four-cell stage (1 h) C: Eight-cell stage (1.25 h). D:
Sixteen-cell stage (1.5 h). E: Thirty-two cell stage (1.75 h). F: Sixty-four cell stage (2 h).
Scale bar = 250 pm.
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Kimmel at al., 1995.

Figure 8: Development during gastrula stage. Left side views, except where noted, with
anterior up and dorsal to the left. A: 50%-epiboly stage (5.25 h). B: Germ ring stage (5.7
h). C: Animal pole view of the germ ring stage; the arrow indicates the germ ring. D:
Shield stage (6 h). The embryonic shield, marking the dorsal side, is visible as a thickening
of the germ ring to the left. E: Animal pole view of the shield stage; the arrow indicates the
embryonic shield. F: 70%-epiboly stage (7.7 h). The anterior axial hypoblast, or prechordal
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plate (arrow), extends nearly to the animal pole. G: 70%-epiboly stage, ventral view, but
tipped slightly forward anteriorly to reveal the now well-delineated axial hypoblast (arrow)
of the prechordal plate. H: 75%-epiboly stage (8 h). I: 80%-epiboly stage (8.4 h), dorsal
view. The arrows indicate the boundaries between axial mesoderm in the midline, and the
paraxial mesoderm flanking to either side. J: 90%-epiboly stage (9 h). The tail bud (arrow)
becomes visible in some embryos at this stage. K: 90%-epiboly stage, ventral view. L: Bud
stage (10 h). The arrow shows the tail bud. Scale bar = 250 pm.

Kimmel et al., 1995.

Creating TCS Zebrafish Model
Zebrafish ortholog of TCOF1 was identified searching with cDNA of Xenopus
tcoft in GenBank (Holser et al., 2007). The predicted protein sequence of ztcof1 was
compared to human, mouse and frog orthologs. It was found that the identity between the
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predicted zebrafish treacle and human’s was 20.8%. This low percentage was also seen in
tcof1 Xenopus ortholog, which was around 19.2% (Gonzales et al., 2005). In addition, the
peritive sequence of acidic and basic residues and the C-terminal containing the nuclear
localizing signals and the nucleolar localizing signal were to be conserved in ztcof1.
Expression pattern of the identified ztcof1 was also examined by in-situ
hybridization, and it was found to be expressed widely during development, especially in
the brain (Holser et al., 2007). This pattern resembled mouse Tcof1 pattern of expression
during development. Expression in both mouse and zebrafish becomes restricted in
branchial archs, limb buds, and the midbrain region in later stages. This uncanny
resemblance in expression, in the branchail archs and midbrain regions in particular, further
supported the hypothesis that the identified gene is indeed the zebrafish Tcof1 ortholog.
To determine in ztcof1 plays a role in craniofacial development in zebrafish, ztcof1
expression was knocked down using morpholinos (MO). MO’s are short, synthetic
antisense oligonucleotides designed to anneal to target mRNA sequences and block
translation by steric hindrance of translation or splicing machinery (Summerton et al.,
1999). Two types of MO’s were used in this study to examine the phenotype after ztcof1
knockdown. One aimed blocked the translation of the mRNA and the other inhibited the
splicing machinery (Holser et al., 2007).
The splice blocking MO targeted splice donor site in exon 2 of ztcof1, preventing
its inclusion and creating a premature stop codon in the resulting aberrantly spliced
transcript. When this MO did not show a phenotype another MO that targeted a donor site
for exon 3 of ztcof1 was used but also did not show a phenotype. Failure to detect a mutant
phenotype, maybe attributed to the presence of maternal pre-spliced transcripts, which were
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found to be abundant at the 8-cell stage using in-situ hybridization. To circumvent this
problem, a translation blocking MO was utilized. This resulted in a phenocopy of the
craniofacial abnormalities seen in TCS mouse models and in patients, including hypoplasia
of the jaw cartilages (Figure 9) (Holser et al., 2007). Using higher concentration of the MO
resulted in loss of cartilage elements in some larvae, starting with Meckel’s cartilage, the
predominant cartilage of the lower jaw.
For further characterization of ztcof1 role in craniofacial cartilage development,
chondrogenesis, which is the differentiation of chondrocytes from mesenchyme, was
examined by measuring the levels of goosecoid (gsc), a marker for this process. By in-situ
hybridization, the expression of gsc was shown to be decreased and the migration of the
chondrocytes constituting the lower jaw was found to be delayed (Holser et al., 2007). In
addition, investigation into yet earlier events, namely cranial crest patterning in the
branchial archs did not show any difference between ztcof1 MO injected embryos and the
uninjected ones.
In an attempt to prevent the neuroepithelial apoptosis that results in craniofacial
hypoplasia, zebrafish embryos were co-injected at 21 hpf with both ztcof1 MO and p53
Figure 9: Translation blocking MO to tcof1 produces hypoplastic craniofacial cartilages as
seen in 4 dpf zebrafish larvae with alcian blue staining
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MO. Embryos showed almost complete rescue of defects that are characteristics of ztcof1
knockdown (Holser et al., 2007). The co-injected embryos had a morphologically normal
brain with little or no dark tissue characteristic of ztcof1 morphants. This finding were

62
further confirmed by TUNEL assay that showed decreased apoptosis in embryos coinjected with both ztcof1 and p53 MO’s compared to un-injected ones (Figure 10).

Figure 10: Embryos co-injected with ztcof1 and p53 MOs display normal midbrain and
hindbrain morphology as seen here at 21 hpf (top row). In addition, cell death in coinjected embryos is reduced to near uninjected levels as seen at 21 hpf.
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CHAPTER 4: P53 Downstream Genes
Introduction

64
The best attempts to rescue the phenotype of TCS were performed by inhibiting
tumor suppressor p53 in Tcof1 heterozygous mice and in zebrafish by co-injecting p53
morpholinos along with that of ztcof. Thus, interrupting the apoptosis pathway of TCS
proved to be sufficient in preventing the onset of the disease in these two animal models.
However, the loss of p53 in mice resulted in tumor formation and this limits the potential
of using this rescue in preventing onset TCS in humans. Therefore, it is important to
identify other members of the apoptotic pathway which if lost, will not cause cancer.
P21 is a very strong candidate for many reasons described earlier in chapter 2. In
addition, p21 homozygous knockout mice do not develop tumors (Deng C et al., 1995)
which overcome the obstacle of tumor formation when p53 is knocked out. The proapoptotic protein, Bnip3l, is another strong candidate that appeared to be upregulated in
TCOF1 knockdown mouse neuroblastoma cell line (Mogass et al., 2004) and may be
down-stream of p53 in the apoptosis pathway. The cell cycle arrest in G1 phase has been
observed in TCS models (Dixon et al., 2008; Lin Li et al., 2006), which makes p27 a
potential member of the pathway. Therefore, the level of expression of these three genes
was examined by in-situ hybridization, in ztcof1 morpholino injected embryos.

Materials and Methods
Zebrafish Culture and Maintenance
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Adult fish were maintained at approximately 28˚C on a 14 hour/10 hour light/dark
cycle. Wild type strains (AB strain or AB/TU) were used for all experiments unless
otherwise indicated. Embryos were incubated at 28˚C until desired stage was reached.
Probe Preparation
Approximately 5 µg of the following plasmids were linearized using the restriction
enzyme EcoRI and approximately 1 µg served as templates for transcription reaction using
the indicated RNA polymerase: pBS-IISK-p27 – T7 RNA polymerase, pBluescript SKBnip3l – T7 RNA polymerase. P21 which was purchased in a pSPORT1 vector (ZFIN) did
not contain an RNA polymerase promoter. Therefore, the p21 plasmid was digested with
EcoRI and the cDNA was amplified with PCR by a T3 promoter coded in the 3’ primer.
The digested plasmids and PCR product were purified for the transcription reaction with
GeneClean purification kit (Qbiogene). Probes were then diluted 1:100 to 1:200 in [50%
formamide, 5x SSC, 50 mg/ml heparin, 500 mg/ml tRNA, 0.1% Tween 20, 9 mM citric
acid].
In situ Protocol
Embryos staged as described by Kimmel et al. (1993) were fixed 24, 48 and 72
hours in 4% paraformaldehyde in 1XPBS (phosphate-buffered saline), hand dechorionated
and dehydrated overnight in methanol at -20°C. Then the embryos were rehydrated
stepwise in methanol/PBT and finally put back in 100% PBT (1´ PBS 0.1% Tween 20).
Embryos older than 24 hours were treated with proteinase K (20 mg/ml in PBT) 1 minute
at room temperature for every hour of embryo age. Prpteinase K was aspirated and
embryos were post-fixed with 4% PFA in 1xPBS for 20 minutes and then washed several
times with 1xPBT 5 times for 5 minutes each. The embryos were prehybridized at least 1
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hour at 65°C in hybridization buffer [50% formamide, 5x SSC, 50 mg/ml heparin, 500 mg/
ml tRNA, 0.1% Tween 20, 9 mM citric acid]. The hybridization was done in the same
buffer containing 50 ng to 100 ng of probe overnight at 70°C. Then the embryos were
washed at 65°C for 10 minutes in [75% hybridization buffer, 25% 2x SSC], 10 minutes in
[50% hybridization buffer, 50% 2x SSC], 10 minutes in [25% hybridization mix, 75%
2xSSC], 10 minutes in 2x SSC, 2 times 20 minutes in 0.2x SSC. Further washes were
performed at room temperature for 5 minutes in [75% 0.2x SSC, 25% PBT], 5 minutes in
[50% 0.2x SSC, 50% PBT], 5 minutes in [25% 0.2x SSC, 75% PBT], 5 minutes in PBT,
and then 1 hour in [PBT with 2 mg/ml BSA (bovine serum albumin), 2% sheep serum].
Then the embryos were incubated overnight at 4°C with the preabsorbed
alkalinephosphatase- coupled anti-digoxigenin antiserum (described in Boehringer) at a
1/10,000 dilution in a PBT buffer containing 2 mg/ml BSA, 2% sheep serum. Finally the
embryos were washed 6 times for 15 minutes each in PBT at room temperature. Detection
was performed in alkaline phosphatase reaction buffer described in the Boehringer. When
the color was developed, the reaction was stopped in 1x PBT and embryos were dehydrated
and cleared in MeOH overnight. The embryos were then rehydrated in MeOH/PBT series
and equilibrated in 50% glycerol in 1 X PBS for viewing and photographing.
Morpholino
Ztcof1 morpholino that was used in this study has been previously described
(Holser, 2007).
Results
Examining the levels of expression of the p27 gene in zebrafish embryos that were
injected with ztcof1 MO showed no difference from the ones that were injected with the
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Mismatch (MM) (Figure 11). However, p21, which is one of the major transcriptional
targets of p53, and is known to be responsible for causing G1 phase cell cycle arrest in
response to a variety of stimuli was found to be upregulated in ztcof1 MO injected embryos
compared to MM injected ones. This was observed in the 24 (data not shown), 48 and 72
hpf (figure 12). Bnip3l, which is also a transcriptional target of p53, was not found to be
upregulated in ztcof1 MO injected embryos as compared to the embryos injected with the
MM (figure 13).
Discussion
p27 is known to bind to cyclin D either alone, or when complexed to its catalytic
subunit CDK4. In doing so, p27 inhibits the catalytic activity of Cdk4, which means that it
prevents Cdk4 from adding phosphate residues to its principal substrate, the retinoblastoma
(pRb) protein. This inhibits the dissociation of E2F-1, which is a transcription factor, from
pRb and hence from mediating the trans-activation of E2F-1 target genes that facilitate the
G1/S transition. Therefore, increased levels of the p27 protein typically cause cells to arrest
in the G1 phase of the cell cycle. However, the in-situ hybridization showed no significant
increase in p27 in MO injected embryos when compared to one injected with the MM. This
indicates that, it could be another G1/S checkpoint that causes the G1 phase cell cycle
arrest observed in TCS.
The CDK inhibitor p21 was upregulated in embryos that were injected with ztcof1
MO compared to embryos injected with the MM. This result is expected because p53 is
stabilized when ztcof1 is knocked down and as was mentioned previously, p53 promotes
transcriptional activation of p21. The exact role of p21 in apoptosis remains unclear, but
the G1 phase cell cycle arrest must be a very important part of it. It would be interesting to
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investigate the potential of rescuing the onset of TCS in any of the models by inhibiting the
expression of p21.
Bnip3l, which is a proapoptotic protein that has a p53 binding sequence in it’s gene,
was not found to be upregulated in embryos injected with the MO, compared to the ones
injected with the MM. Therefore, it is more likely that the apoptosis does not involve
Bnip3l.
Future work
In summary, when Tcof1 is reduced, ribosome biogenesis is affected and this leads
to the activation of p53 through its stabilization. In turn, p53 promotes G1 phase cell cycle
arrest and ultimately apoptosis. The inhibition of this apoptosis pathway, by inhibiting p53
expression, proved to be sufficient in preventing the onset of TCS in the mouse model
(Dixon et al., 2008). The fact that most mice in this rescue developed tumors within 3 to 6
months limits the potential of using it when treating TCS in humans. Therefore, further
studies should be performed to find other members in this pathway and try to rescue the
phenotype using this knowledge.
When ribosome biogenesis is impaired, L11 diffuse into the nucleoplasm where it
sequesters HDM2, ultimately stabilizing p53 (Lohrum et al., 2003). This could be
occurring upstream of p53-mediated cell cycle arrest and apoptosis seen in TCS. A rescue
experiment could be performed by the inhibition of the expression of L11. This should be
first investigated using the zebrafish model, by the co-injection of ztcof1 MO and L11 MO
followed by TUNEL assay to test if the knockdown of L11 would prevent the
neuroepithelial apoptosis and rescue phenotype.
After seeing an increased level of expression of the Cdk inhibitor, p21, following
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the knock down of ztcof1 in zebrafish embryos, the possibility of preventing the onset of
TCS by blocking p21 is raised. The most informative and suitable model to use for this
rescue is TCS mouse model obtained by breeding DBA Tcof1+/- mice and C57BL/6 wild
type mice to generate mixed DBA x C57BL/6 F1 progeny (Dixon, J et al., 2006). F1
progeny of DBA Tcof1+/- mice bred with C57BL/6 p21

+/-

to generate compound Tcof1+/-

p21 +/- mice, will be compared to DBA Tcof1+/- mice bred with C57BL/6 wild type mice as
controls. Morphology of the head can then be assessed. In addition, to evaluate the efficacy
of p21 inhibition in preventing the pathogenesis of TCS, the segregated streams of
migrating cranial neural crest cells can be examined using in-situ hybridization detecting
Sox10 (at E9.0) which is a cranial neural crest marker (reviewed in Kelsh RN et al., 2006).
If inhibition of p21 should prevent the pathogenesis of TCS, in-situ hybridization would
show the discrete segregated migrating streams of neural crest cells resembling wild type.
Another rescue experiment can be performed using the zebrafish model by the co-injection
of ztcof1 and p21 morpholinos followed by TUNEL assay to test if the knockdown of p21
will prevent apoptosis.
The microarray study (Mogass et al., 2004) revealed a number of genes that were
found to be positively or negatively correlated with TCOF1 expression. These results
should be confirmed with RT-PCR which would also reveal the extent of that correlation.
Strongly correlated genes should then be investigated according to their functional
classification, as either cell cycle genes, metabolism genes... etc.
For example, Rasa1, a known cell cycle protein, was found to be coordinately
regulated with Tcof1 expression. Rasa1 is known to reduce p38 MapK activity through the
promotion of GDP-Ras so less phosphate is available for phosphorylation. P38 MapK is a
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member of mitogen-activated protein kinases and is known to activate p53 by directly
phosphorylating the protein. Therefore, there is a possibility that L11 protein is promoting
p53 stabilization while increased levels of p38 MapK is promoting activation of the protein
by directly phophorylating it, when Tcof1 is knocked down. The levels of p38 Mapk
protein should be tested by Western Blot in the TCOF1 knocked down neuroblastoma cell
line. Due to decreased levels of Rasa1, it is expected that protein levels of p38 Mapk be
increased in the TCOF1 knocked down cell line.
If levels of p38 MapK were found to be elevated, it would be interesting to
investigate the potential of inhibiting the expression of this protein to prevent apoptosis.
Although previous experiments to inhibit the neuroepithelial apoptosis by knocking out
p53 resulted in tumors, inhibiting the phosphorylation of p53 by p38 MapK would not
affect phophorylation mediated by kinases implicated in the genome integrity checkpoints.
This would overcome the obstacle of tumor formation when p53 in knocked out. Another
protein called fatty acid binding protein-3 (Fabp3) was found to be negatively correlated
with Tcof1 expression. Fabp3 is also called mammary derived growth inhibitor (MDGI)
due to its potential role as an anti-tumor protein. Due to abnormally increased levels of this
protein when TCOF1 is knocked down, it is possible that it may be mediating apoptosis
seen in TCS. Therefore, it would be interesting to inhibit the expression of this protein in
the TCOF1 KD neuroblastoma cell line using siRNA, and then assess apoptosis by TUNEL
assay and see if the inhibition reduces apoptosis.
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Figure 11: p27 expression was found to be the same in the MO injected embryos and MM
in the 48 and 72 hpf. a and c show MM injected embryos at 48 and 72 hpf respectively. b
and d show MO injected embryos at 48 and 72 hpf respectively.

72

a

b

c

d

Figure 12: The level of expression of p21 was found to be increased in embryos that were
injected with the MO compared to the ones injected with the MM at both the 48 and 72 hpf
stages. a and c show MM injected embryos at 48 and 72 hpf respectively. b and d show
MO injected embryos at 48 and 72 hpf respectively

73

a

b

c

d

Figure 13: Bnip3l expression was found to be the same in the MO injected embryos and
MM in the 48 and 72 hpf. a and c show MM injected embryos at 48 and 72 hpf
respectively. b and d show MO injected embryos at 48 and 72 hpf respectively.
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